If you need more lookups,
subscriptions start at $34 USD/month.
Sajjan Daniel Location
Stamford, CT, US
Sajjan Daniel Work
2020 -now Vice President, Head of Drug Safety and Pharmacovigilance @
2018 -2020 Vice President, Global Head of Drug Safety @
2016 -2018 Vice President, Global Head of Drug Safety Surveillance @
2015 -2016 Vice President, Global Head of Medical Safety Surveillance @
2013 -2015 Therapeutic Area Head for CNS Products for Pharmacovigilance @
2012 -2013 Global Head of PV Medical Science Group @
2012 -2012 Therapeutic Area Head for Cardiovascular and Renal Products @
2012 -2012 President - Pharmacovigilance Consulting Firm @ Sajjan Daniel Inc.
2009 -2012 Therapeutic Area Head of Pain and Inflammation, Senior Director @
2007 -2009 Therapeutic Area Lead for Benefit Risk Management @
2006 -2007 Global Head of Medical Safety Analysis @
2005 -2006 Global Head of Safety Operation @
2003 -2004 Medical Safety Expert - Team Leader @
Sajjan Daniel Education
Bachelors of Science (Biology, Chemistry, Buisness)
Debrecen Medical University
Medical Degree (Medicine)
Sajjan Daniel Skills
Medicine
Clinical Development
Pharmacovigilance
Drug Development
Pharmaceutical Industry
Regulatory Submissions
CTMS
GCP
Clinical Trials
Oncology
Medical Affairs
Regulatory Affairs
CRO
Neurology
Health Economics
Infectious Diseases
FDA
Clinical Research
SOP
Pharmaceutics
Cardiology
Pharmacology
Drug Safety
Medical Writing
Regulatory Requirements
EDC
Protocol
Life Sciences
Biotechnology
Good Clinical Practice (GCP)
CRO Management
Rare Diseases
Immunology
Hematology
Standard Operating Procedure (SOP)
Queries
Scientific
EKG
History
Dissemination
Clinics
Analysis
Monitors
Multi Functional
Site Investigation
Anticoagulation
Succession Planning
Therapeutic Area
Efficacy
Study Reports
Medical Review
Google Groups
Pulse
Flow Cytometry
Stain
Risk
Rescue
Forums
Strategic Planning
Malayalam
Neuroscience
Perspective
Pfizer
Hindi
Clinical Protocols
Ccds
Strategies
Responsibility
Safety
Case Report Forms
Cdt
Melanoma
European Union
Languages
Laboratory
PC
Lotus
Coordinating Activities
OTC
Drug Product
System
Prioritizes
Elevations
ICU
Emergency Medical
Clinical Data
Workflow
Canada
Rmp
Reports
Blood
Outsourcing
Disease
Neo
IV
Stakeholders
New York
Information Quality
Mentoring
Vendor Management
Medical Records
Business Units
Project
Silver
Microsoft Word
Aggregate
SSOP
Data Management
STEM
Human Resources
Databases
Strategy
Medical Directors
Tests
Therapeutic Areas
Assessment
Measurements
Chemistry
Safety Engineering
Reporting
Trust
Compilation
MHRA
Laptops
Competition
PVC
PCR
Project Portfolio Management
Checking
Trending
Cardiovascular Disease
Proposal Writing
Presentations
Medical History
Narrative
Cros
English
RIA
Investigation
Quality Control
Expedited
Phase Ii
Ndas
Andas
Adobe Contribute
Academic
Bridging
Risk Management
Regulatory Reporting
Metrics
Significance
Hungarian
Montreal
C
Radio Access Network
Pediatrics
Licensing Agreements
Cell
Psur
Consumption
EMEA
UPS systems
Novartis
French
Product Safety
Corrective Actions
Quality Assurance
Inclusion
Units
Public Health
Advertising
Teaching Hospitals
Argus Safety
Science
Diet
Platinum
Third Parties
Inflammation
Death
International
Spontaneous
Summaries
Stress
ARISg
Clinical Monitoring
Operations
Addendums
Stroke
Sae
Legal
Sampling
Research
PV
Independent Contributor
Western Blotting
Data Analysis
Travel
System Monitoring
North American
Communication
Call Centers
Revision
Customer Service
Pharmaceutical Research
Injured
Public Speaking
Regulations
Writes
Addressing
NDA
Fulfilment
ELISA
Process Improvement
Brochures
Filtration
Colleague Development
Art
Adverse Events
Gel
Pacemakers
Paper
Spectrophotometry
Individual Development
Committees
Training
FIX Protocol
Corporate Governance
Schedules
Clinical Expertise
Risk Assessment
Searches
Liaise
Data Collection
Resolve
Supervision
Project Planning
MDS
Outlook
Latin
Coordination
Medical Coding
Licensing
Compliance
Notification
Instrumentation
Hungary
Risk Analysis
Writers
Windows
Ade
Microsoft Exchange
Regulatory Operations
Investigator Brochures
Scripting
Cardiac Surgery
Performance Management
Hla
Surveillance
Context
Management
Healthcare
Epidemiology
Evaluations
Chromatography
Literature Reviews
Treatment
Physicians
DNA extraction
ICH guidelines
Policy
Sequence
Combination
Coordinate
Global Strategy
SBT
Labelling
Bone Marrow
High Resolution
Internal Medicine
Putting
Cdp
Accountability
Argus
Surgery
Gel Electrophoresis
Microsoft Excel
Annual Reports
Water Analysis
Expert Reports
Publications
Sceptre
Academic Background
Encore
Consumer
PowerPoint
Good Clinical Practice Gcp
Marketing
Patient
Heart Valves
Internal Audit
Governance
Hudson
Families
Literature
Daily Operations
Meetings
Coding Practices
Bridge Inspection
Writing
Psurs
Product Support
Documentation
Conventions
Executive Management
Microsoft Office
Guidelines
Breast Cancer
Written
Timelines
Evaluation
Contractual Agreements
Sers
Temporary Placement
Police
Detection
Microsoft Publisher
AES
Emergency Medicine
EMT
Data Review
American
Reviews
Crisis Management
BRMS
Biology
Cardiac
Protocol Review
Forms
Regulatory Knowledge
Clinical Study Design
Scholarships
Hospitals
Culture
Alcohol
Surgeons
Pain Management
Applications
Harmonization
Factor
Good Clinical Practice
Sajjan Daniel Summary
Sajjan Daniel, based in Stamford, CT, US, is currently a Vice President, Head of Drug Safety and Pharmacovigilance at Purdue Pharma L.P.. Sajjan Daniel brings experience from previous roles at Amicus Therapeutics, Shire, Baxalta and Takeda Pharmaceuticals. Sajjan Daniel holds a Bachelors of Science in Biology, Chemistry, Buisness. With a robust skill set that includes Medicine, Clinical Development, Pharmacovigilance, Drug Development, Pharmaceutical Industry and more. Sajjan Daniel has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Sajjan Daniel?
Find contact details for 700 million professionals.